HR 3082 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Evidence-Based Drug Policy Act of 2025
To repeal section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998, and for other purposes.
Summary
- Repeals section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
-
![Rep. Titus, Dina [D-NV-1]](https://media.civicgate.org/people/d/politicians/T000468.thumb.jpg)
Rep. Titus, Dina (D-NV) [#1]
2 cosponsors
-
![Del. Norton, Eleanor Holmes [D-DC-At Large]](https://media.civicgate.org/people/d/politicians/N000147.thumb.jpg)
Del. Norton, Eleanor Holmes (D-DC) [At-large] -
![Rep. Omar, Ilhan [D-MN-5]](https://media.civicgate.org/people/d/politicians/O000173.thumb.jpg)
Rep. Omar, Ilhan (D-MN) [#5]
Money behind the sponsor
Top reported contributors to Dina Titus’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- Employer not reported $42,666
- EO SOLUTIONS $19,800
- ROCKY RESEARCH $13,200
- UNLV $11,275
- MASS GENERAL HOSPITAL $6,600
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Dina Titus → · Outside spending →
Actions (2)
- Apr 29, 2025 Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
- Apr 29, 2025 Introduced in House
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
April 29, 2025
Ms. Titus (for herself and Ms. Omar) introduced the following bill; which was referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To repeal section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Evidence-Based Drug Policy Act of 2025”.
SEC. 2. REPEAL OF SECTION 704(B)(12) OF THE OFFICE OF NATIONAL DRUG CONTROL POLICY REAUTHORIZATION ACT OF 1998.
Section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1703(b)(12)) is repealed. <all>
Comments